The Hong Kong International Capital Markets and M&A Forum

The Hong Kong International Capital Markets and M&A Forum

Last week, ARC Group hosted The Hong Kong International Capital Markets and M&A Forum at the The Murray, Hong Kong, a Niccolo Hotel, bringing together a select group of seasoned professionals in cross-border M&A and Capital Markets.

This insightful event brought together brilliant minds who shared insights into key topics including evolving market trends, strategic opportunities, and the dynamic interplay between Asian, European, and North American markets.

A heartfelt thank you to all our participants and speakers for their valuable contributions and making this event a success.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission